Overview
Albin (Jim) Nelson is a registered patent attorney and senior principal/owner of Schwegman Lundberg & Woessner with over 40 years of experience in the intellectual property (IP) field. Dr. Nelson’s practice focuses on IP preparation and prosecution, counseling, infringement and validity opinions, reissues, Inter Partes Reviews (IPR’s), litigation counseling, associated FDA work and adversarial practice in chemical, polymer, pharmaceutical, biotechnology, cosmetics and medical device fields. Dr. Nelson handles IP and general legal company issues for companies throughout the United States, Canada and Europe with special emphasis on launching new initiative efforts, and development of portfolio assets. Dr. Nelson has presented seminars on IP prosecution, opinion and litigation practice at pharmaceutical/biotechnology and chemical conferences throughout the world.
Dr. Nelson received his B.S. honors in chemistry, cum laude, University of Iowa (1968), his Ph.D. in organic chemistry from the Iowa State University (1972, NASA Fellow, Phi Kappa Phi) and his J.D. from Fordham University (1980;). Dr. Nelson is a member of the Minnesota State Bar, 1989; New York State Bar, 1980; U.S. Patent Bar, 1976; and the U.S. District Court Bar, Minnesota, 1994. Dr. Nelson practiced IP law with organizations and law firms in New York and Minnesota during his career as a patent attorney.
Education
Fordham University School of Law
New York, NY, J.D., 1980
Law Review: Fordham Law Review
Iowa State University
Ames, Iowa, Ph.D, 1972
NASA Fellow
Phi Kappa Phi
Organic Chemistry
University of Iowa
Iowa City, Iowa, B.S., 1968
Cum Laude, Honors in Chemistry
Bar Admissions & Associations
Bar Admissions
New York
Minnesota
U.S. Patent and Trademark Office
U.S. District Court, District of Minnesota
Phi Kappa Phi
Classes/Speaking Engagements
Conferences on Biosimilars London and USA SMI 2014, 2015, 2016 presentations regarding new BPCIA USA rules and US IPR’s
European Conference on Pharmaceuticals and Intellectual Property
World Congress for Pharmaceuticals and biotechnology 2016
Biotechnology and Pharmaceutical Pre-Litigation Analysis, Strategic Research Institute
Advanced Biotechnology and Chemical Patent Practice, American Intellectual Property Lawyers Association
Freedom to Operate Opinions, American Conference Institute
IP Prosecution and Opinion Practice, Minnesota Intellectual Property Lawyers Association
IP Prosecution and Opinion Practice, Minnesota Institute of Legal Education
IP Prosecution and Opinion Practice, American University Technology Managers Association
IP Prosecution and Opinion Practice, The Cosmetic Society
IP Prosecution and Opinion Practice, Fresenius Institute of Biotechnology (Germany)
IP Prosecution and Opinion Practice, American Intellectual Property Lawyers Association
IP Litigation, Indian Chemical Association
Hatch Waxman Practice, Marcus Evans Organization
Pharmaceutical, Life Cycle Management, C5 London
Obtaining and Protecting Pharmaceutical Patents – Novartis
Representative Clients
Cleave Bioscience
Female Health Company
Aspen Technology
Phenomix
Atrix/QLT
Restoragen
The Scripps Research Institute
BioGeneriX
Smith Industries
Geneticure
Coty
BYK-Chemie GmbH
